Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Eckerdal"'
Publikováno v:
EFORT Open Reviews, Vol 9, Iss 7, Pp 625-631 (2024)
Purpose: Controversy exists regarding the comparative efficacy of collagenase injection and percutaneous needle fasciotomy in the treatment of Dupuytren contracture. The randomized controlled trials (RCTs) that have compared the two treatment methods
Externí odkaz:
https://doaj.org/article/a67bfa9362f949e9b6c2e7ae2405df8e
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/bf7572fcc3534d338737f1d15ac1c1a3
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-8 (2023)
Abstract Background Patients with Dupuytren disease experience various activity limitations. Treatment aims to reduce finger joint contractures to improve hand function and activity performance. For assessing improvement different patient-centered me
Externí odkaz:
https://doaj.org/article/94d64ae0f9d2427690dfbde983377e00
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 699 (2023)
In Dupuytren disease, little is known about the long-term outcomes of collagenase injection or risk factors for contracture recurrence. In this prospective study, 159 patients (242 fingers) with Dupuytren disease and active extension deficit (AED)
Externí odkaz:
https://doaj.org/article/ccf734107a574b3da29721c8cde9253f
Publikováno v:
The Journal of hand surgery. 47(9)
To compare collagenase injection with surgical fasciectomy in Dupuytren disease (DD) for the prevalence of contracture in treated fingers 5 years after treatment.This was a single-center, comparative cohort study comprising 2 cohorts of patients trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8226cd5374dfc92b4a9d9bb41a448a
https://pubmed.ncbi.nlm.nih.gov/35868901
https://pubmed.ncbi.nlm.nih.gov/35868901
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders; 15(Apr 2), no 117 (2014)
BMC Musculoskeletal Disorders; 15(Apr 2), no 117 (2014)
Background: The conventional treatment for Dupuytren’s disease is surgery. The introduction of alternative treatment strategies creates a need to track outcomes and costs relating to surgical treatment and risk factors, such as smoking and diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181aa97e4bc5c7a00797587aba560494